Danaher (NYSE:DHR – Get Free Report) issued its quarterly earnings data on Tuesday. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.15, Briefing.com reports. Danaher had a return on equity of 10.90% and a net margin of 16.94%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the business earned $2.05 earnings per share. The business’s revenue was down 2.9% on a year-over-year basis.
Danaher Stock Performance
NYSE:DHR traded up $4.33 during midday trading on Thursday, reaching $270.09. 4,248,613 shares of the company traded hands, compared to its average volume of 2,922,813. The firm has a market capitalization of $200.05 billion, a price-to-earnings ratio of 45.04, a price-to-earnings-growth ratio of 4.11 and a beta of 0.83. The company has a fifty day moving average price of $254.89 and a 200 day moving average price of $248.67. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. Danaher has a twelve month low of $182.09 and a twelve month high of $276.31.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a yield of 0.40%. Danaher’s dividend payout ratio is currently 18.31%.
Insiders Place Their Bets
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the stock. The Goldman Sachs Group lifted their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday. TD Cowen upped their price target on Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday. Barclays raised their price objective on Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a report on Wednesday. Jefferies Financial Group initiated coverage on Danaher in a report on Monday, June 3rd. They set a “buy” rating and a $295.00 target price for the company. Finally, Stifel Nicolaus increased their price target on Danaher from $235.00 to $250.00 and gave the company a “hold” rating in a report on Wednesday. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $276.88.
Get Our Latest Analysis on DHR
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- How to Calculate Options Profits
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What is the FTSE 100 index?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.